Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Ann Med Res. 2017; 24(4): 497-499


Concurrence of polyostotic fibrous dysplasia and spinal aspergillus in non-immunocompromised adult patient:case report

Ramazan Pasahan, Mehmet Akif Durak, Mehmet Arif Aladag, Ayşe Nur Akatli, Ismail Okan Yildirim.




Abstract
Cited by 0 Articles

Aspergillus, a rare agent in spinal infections, is often transmitted via inhalation. It can be traced as an infectious agent in immunocompromised
patients. While in non-immunocompromised patients, it is highly unlikely to cause spondylodiscitis. Radiological findings
remind tuberculosis. The recommended medical treatment is applied with Itraconazole and Amphotericin B. Surgical indication
involves the presence of progressive neurological deficit, instability and biopsy requirement.
Fibrous dysplasia was first reported in 1938 by Lichtenstein and is a benign developmental disorder of the skeletal system with
uncertain etiology. Polyostotic type involved more than one bone, while the monostotic type occurs by involving only one bone
structure. Spinal involvement may lead to collapse fractures and deformity development and the most common complaint is pain.
In our case, these two disorders occur concurrently, causing bone destruction and severe pain, and no similar cases were found in
the literature.

Key words: Fibrous Dysplasia; Spinal Aspergillus Ifection; Non-Immunocompromised.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.